Year-end Sale % OFF 
Abstract
We sought to examine the relationship between frailty and health-related quality of life as evaluated using the 36-item Short-Form Health Survey (SF-36) questionnaire in Japanese chronic liver disease (CLD) patients (n = 341, 122 liver cirrhosis cases, median age = 66 years). Frailty was defined as a clinical syndrome in which three or more of the following criteria were met (frailty score 3, 4, or 5): unintentional body weight loss, self-reported exhaustion, muscle weakness (grip strength: <26 kg in men and <18 kg in women), slow walking speed (<1.0 m/s), and low physical activity. Robust (frailty score 0), prefrail (frailty score 1 or 2), and frailty were found in 108 (31.7%), 187 (54.8%), and 46 (13.5%) patients, respectively. In all eight scales of the SF-36 (physical functioning, role physical, bodily pain, general health perception, vitality, social functioning, role emotion, and mental health), and the physical component summary score and mental component summary score, each score was well stratified according to the frailty status (all p < 0.0001). In the multivariate analysis, age (p = 0.0126), physical functioning (p = 0.0005), and vitality (p = 0.0246) were independent predictors linked to the presence of frailty. In conclusion, Japanese CLD patients with frailty displayed poorer conditions, both physically and mentally.
Highlights
Health-related quality of life (Hr-QoL) is a globally used patient-reported clinical outcome for patients with various diseases and the number of pivotal clinical trials with Hr-QOL as additional study endpoints has been increasing [1,2,3,4,5,6]
We retrospectively examined the relationship between the frailty status and the values of the eight scales of SF-36, the physical component summary score (PCS), and the mental component summary score (MCS)
To the best of our knowledge, this is the first study elucidating the relationship between frailty and Hr-QoL as assessed using the SF-36 in Japanese patients with chronic liver disease (CLD)
Summary
Health-related quality of life (Hr-QoL) is a globally used patient-reported clinical outcome for patients with various diseases and the number of pivotal clinical trials with Hr-QOL as additional study endpoints (most of them are secondary endpoints) has been increasing [1,2,3,4,5,6]. CLDs should be a pivotal treatment goal because of their unfavorable clinical and patient-reported outcomes and economic burdens [7,8,9,10,11,12,14,15]. The concept of frailty has been enlarged to CLDs as clinical symptoms of impaired global physical function [14,24]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
